Physician profile
Michael Blake Streiff
NPI 1932134814
$53,451.72
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,122 · 2020: $15K · 2021: $4,500 · 2022: $3,924 · 2023: $20K · 2024: $3,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $1,684 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $229 · Food and Beverage: $123 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $91.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,653.92 |
| Travel and Lodging | $1,683.85 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $228.66 |
| Food and Beverage | $122.56 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $91.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $20,375.50 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $13,756.93 | 2020-2023 | |
| Csl Behring | $10,853.92 | 2023-2024 | Kcentra |
| Merck Sharp & Dohme LLC | $5,250.00 | 2023 | |
| Janssen Scientific Affairs, LLC | $1,595.77 | 2019-2022 | |
| Janssen Research & Development, LLC | $1,200.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $299.72 | 2023 | |
| Taiho Oncology, INC. | $119.88 | 2023 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Streiff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.